LivaNova Plc (LIVN)
63.06
+0.31
(+0.49%)
USD |
NASDAQ |
Dec 15, 16:00
63.06
0.00 (0.00%)
After-Hours: 20:00
LivaNova Free Cash Flow: 191.43M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| NovoCure Ltd. | -65.17M |
| Abbott Laboratories | 6.917B |
| ResMed, Inc. | 1.757B |
| Perspective Therapeutics, Inc. | -106.85M |
| Xtant Medical Holdings, Inc. | 5.123M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 85.06M |
| Cash from Investing (Quarterly) | -23.06M |
| Cash from Financing (Quarterly) | -9.373M |
| Free Cash Flow Per Share (Quarterly) | 1.127 |
| Free Cash Flow to Equity (Quarterly) | 58.41M |
| Free Cash Flow to Firm (Quarterly) | 70.76M |
| Free Cash Flow Yield | 5.54% |